Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis

Several drugs in development for nonalcoholic fatty liver disease (NAFLD) aim to decrease the amount of fat in the liver. We compared quantity and quality of fat in subcutaneous, visceral and muscle compartments, liver fibrosis, and prevalence of metabolic abnormalities between Chinese patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Huang, Rui, Wang, Yi, Rao, Huiying, Wei, Lai, Su, Grace L., Lok, Anna S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887912/
https://www.ncbi.nlm.nih.gov/pubmed/31832569
http://dx.doi.org/10.1002/hep4.1435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887912/
https://www.ncbi.nlm.nih.gov/pubmed/31832569
http://dx.doi.org/10.1002/hep4.1435

Ejemplares similares